Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,544 | 26 | 85.0% |
| Education | $272.99 | 3 | 15.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $632.46 | 5 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $255.74 | 7 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $217.07 | 4 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $205.80 | 6 | $0 (2021) |
| Astellas Pharma US Inc | $173.99 | 2 | $0 (2018) |
| Boston Scientific Corporation | $146.64 | 1 | $0 (2024) |
| Amgen Inc. | $119.32 | 1 | $0 (2017) |
| Novo Nordisk Inc | $39.74 | 2 | $0 (2021) |
| PFIZER INC. | $26.02 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $146.64 | 1 | Boston Scientific Corporation ($146.64) |
| 2023 | $160.50 | 2 | Abbott Laboratories ($134.48) |
| 2022 | $60.96 | 3 | Novartis Pharmaceuticals Corporation ($60.96) |
| 2021 | $269.43 | 7 | Abbott Laboratories ($148.78) |
| 2020 | $72.76 | 4 | Janssen Pharmaceuticals, Inc ($49.01) |
| 2019 | $145.66 | 2 | Janssen Pharmaceuticals, Inc ($145.66) |
| 2018 | $542.52 | 6 | Abbott Laboratories ($325.45) |
| 2017 | $418.31 | 4 | Novartis Pharmaceuticals Corporation ($125.00) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/16/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $146.64 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/02/2023 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/07/2023 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $134.48 | General |
| Category: Vascular | ||||||
| 05/17/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/12/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/03/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/17/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/10/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/18/2021 | Abbott Laboratories | MitraClip System (Device) | Food and Beverage | In-kind items and services | $148.78 | General |
| Category: Structural Heart | ||||||
| 07/16/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/29/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/06/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Diabetes | ||||||
| 03/16/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Diabetes | ||||||
| 12/16/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/14/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/06/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/20/2020 | Abbott Laboratories | Confirm Rx (Device) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 06/27/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/07/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/14/2018 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $150.55 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 07/27/2018 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.00 | General |
| 07/12/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/12/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $1.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/11/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $105.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/14/2018 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $174.90 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,066 | 1,445 | $958,546 | $153,157 |
| 2022 | 9 | 878 | 1,209 | $784,617 | $131,242 |
| 2021 | 11 | 688 | 908 | $527,583 | $102,609 |
| 2020 | 8 | 354 | 455 | $277,168 | $50,943 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 166 | 296 | $289,784 | $45,147 | 15.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 158 | 324 | $149,040 | $34,993 | 23.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 147 | 148 | $130,092 | $22,633 | 17.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 89 | 92 | $136,775 | $15,950 | 11.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 93 | 93 | $85,281 | $12,629 | 14.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 112 | 121 | $44,257 | $6,461 | 14.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 20 | 28 | $37,436 | $5,503 | 14.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 238 | 300 | $41,700 | $3,650 | 8.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 19 | 19 | $27,645 | $3,429 | 12.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 24 | $16,536 | $2,762 | 16.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 148 | 324 | $149,040 | $31,047 | 20.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 97 | 188 | $184,052 | $29,394 | 16.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 136 | 140 | $123,060 | $25,304 | 20.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 92 | 96 | $141,638 | $17,006 | 12.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 79 | 79 | $72,443 | $11,925 | 16.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 113 | 114 | $41,697 | $6,940 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 28 | $19,292 | $3,452 | 17.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 159 | 211 | $29,329 | $2,727 | 9.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 13 | 13 | $18,915 | $2,366 | 12.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 16 | $5,152 | $1,081 | 21.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 105 | 239 | $109,940 | $23,359 | 21.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 112 | 115 | $101,085 | $22,314 | 22.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 55 | 89 | $57,049 | $15,052 | 26.4% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 63 | 63 | $93,304 | $12,044 | 12.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 71 | 71 | $52,256 | $10,797 | 20.7% |
About Dr. Robert Faigen, M.D
Dr. Robert Faigen, M.D is a Cardiovascular Disease healthcare provider based in Manhasset, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2013. The National Provider Identifier (NPI) number assigned to this provider is 1841633062.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Faigen, M.D has received a total of $1,817 in payments from pharmaceutical and medical device companies, with $146.64 received in 2024. These payments were reported across 29 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,544).
As a Medicare-enrolled provider, Faigen has provided services to 2,986 Medicare beneficiaries, totaling 4,017 services with total Medicare billing of $437,951. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Manhasset, NY
- Active Since 04/08/2013
- Last Updated 06/27/2019
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1841633062
Products in Payments
- CardioMEMS HF System (Device) $325.45
- BRILINTA (Drug) $217.07
- XARELTO (Drug) $205.80
- ENTRESTO (Drug) $194.78
- MitraClip System (Device) $148.78
- WATCHMAN FLX (Device) $146.64
- MITRACLIP (Device) $134.48
- Repatha (Biological) $119.32
- LEQVIO (Drug) $60.96
- Ozempic (Drug) $39.74
- VYNDAQEL (Drug) $26.02
- Confirm Rx (Device) $23.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Manhasset
Bruce Rutkin, Md, MD
Cardiovascular Disease — Payments: $328,717
Mitchell Weinberg, Md, MD
Cardiovascular Disease — Payments: $163,984
Dr. Perwaiz Meraj, M.d, M.D
Cardiovascular Disease — Payments: $121,905
Dr. Benjamin Hirsh, M.d, M.D
Cardiovascular Disease — Payments: $50,588
Dr. Andrea Mignatti, M.d, M.D
Cardiovascular Disease — Payments: $24,976
Michael Mannino, M.d, M.D
Cardiovascular Disease — Payments: $20,568